Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cosmos Health Inc - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES
Ticker
Exchange
SIC #
Website
Latest Ticker
COSM
Nasdaq
5122
http://www.cosmosholdingsinc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cosmos Health Inc
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
- Mar 24th, 2023 2:35 pm
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
- Mar 17th, 2023 5:45 pm
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories
- Mar 7th, 2023 2:15 pm
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
- Mar 3rd, 2023 1:25 pm
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
- Feb 15th, 2023 8:30 pm
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests
- Feb 7th, 2023 2:15 pm
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
- Feb 7th, 2023 1:30 pm
Cosmos Health Announces Application for Dual Listing on Upstream
- Feb 2nd, 2023 6:50 pm
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
- Feb 1st, 2023 4:00 pm
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
- Jan 26th, 2023 8:00 pm
Cosmos Health Announces Stock Buyback Program
- Jan 24th, 2023 5:40 pm
Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp
- Jan 20th, 2023 6:40 pm
Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense
- Jan 17th, 2023 2:15 pm
Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company
- Jan 10th, 2023 4:55 pm
Cosmos Health Regains Nasdaq Minimum Bid Price Compliance
- Jan 5th, 2023 2:05 pm
Cosmos Health CEO Participated in the Last Fundraising of the Company
- Dec 22nd, 2022 4:40 pm
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
- Dec 21st, 2022 9:10 pm
Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
- Dec 19th, 2022 2:12 pm
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split
- Dec 15th, 2022 12:45 pm
Cosmos Health Retains Shareholder Intelligence Services, LLC
- Dec 9th, 2022 4:30 pm
Scroll